1
ABBV
ABBVIE INC · Health Care
Consensus score 1/100 · #271 this quarter · tier-weighted across tracked managers
↑ConfirmedPrice action since filingas of 2026-06-05
vs 50-day avg
+8.4%
21-day momentum
+10.8%
recent volume
0.84×
13F filings lag ~45 days; this is current price/volume action on top — a technical read, not a prediction.
S2· AdvancingStage Analysis · Weinstein
vs 30-wk avg
+3.6%
30-wk MA slope
-1.1%
rel. strength
-4.4
52-wk range
72%
Advancing — above a rising 30-week trend with positive relative strength. Weinstein’s buy zone. Based on the 30-week (150-day) moving average + slope, Mansfield relative strength vs SPY, and volume. Technical read, not advice.
Holders
3
tracked managers
New this Q
1
opened a position
Avg weight
0.3%
of their portfolios
Combined value
$45M
held, at quarter-end
Who’s holding it Q2 2026, by position size
| Manager | Position size | Value | Change |
|---|---|---|---|
| Glenview Capital Concentrated | 0.7% | $37M | NEW |
| Horizon Kinetics Franchise/inflation | 0.1% | $5M | TRIM |
| Gardner Russo & Quinn Graham/global value | 0.0% | $3M | HOLD |
Position size = share of that manager’s reported long US-equity portfolio. The consensus score weights each holder by quality tier, position size, and whether they were buying or trimming — then discounts very crowded names. It measures agreement among these managers, not expected return.